Oral Superoxide Dismutase (GLISODin) to Decrease Melasma Severity.
Clinical trial NCT03878433 · COMPLETED
Trial details
- NCT number
- NCT03878433
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2020-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.